188 related articles for article (PubMed ID: 19258429)
1. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity.
Guan HT; Xue XH; Dai ZJ; Wang XJ; Li A; Qin ZY
World J Gastroenterol; 2006 May; 12(18):2901-7. PubMed ID: 16718816
[TBL] [Abstract][Full Text] [Related]
3. Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors.
Hurtado M; Sankpal UT; Kaba A; Mahammad S; Chhabra J; Brown DT; Gurung RK; Holder AA; Vishwanatha JK; Basha R
Cell Physiol Biochem; 2018; 51(4):1894-1907. PubMed ID: 30504717
[TBL] [Abstract][Full Text] [Related]
4. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
Abdelrahim M; Baker CH; Abbruzzese JL; Safe S
J Natl Cancer Inst; 2006 Jun; 98(12):855-68. PubMed ID: 16788159
[TBL] [Abstract][Full Text] [Related]
5. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
Pathi S; Li X; Safe S
Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of survivin and hypoxia-inducible factor-1 α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft.
Li G; Xie B; Li X; Chen Y; Wang Q; Xu Y; Xu-Welliver M; Zou L
Cancer Biother Radiopharm; 2012 Feb; 27(1):56-64. PubMed ID: 22248028
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines.
Iwasa T; Okamoto I; Suzuki M; Nakahara T; Yamanaka K; Hatashita E; Yamada Y; Fukuoka M; Ono K; Nakagawa K
Clin Cancer Res; 2008 Oct; 14(20):6496-504. PubMed ID: 18927289
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
[TBL] [Abstract][Full Text] [Related]
11. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells.
Sankpal UT; Goodison S; Jones-Pauley M; Hurtado M; Zhang F; Basha R
Oncotarget; 2017 Feb; 8(9):14593-14603. PubMed ID: 28099934
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
Eslin D; Lee C; Sankpal UT; Maliakal P; Sutphin RM; Abraham L; Basha R
Tumour Biol; 2013 Oct; 34(5):2781-9. PubMed ID: 23686785
[TBL] [Abstract][Full Text] [Related]
13. Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.
Xue J; Zhu W; Song J; Jiao Y; Luo J; Yu C; Zhou J; Wu J; Chen M; Ding WQ; Cao J; Zhang S
Oncogene; 2018 Feb; 37(7):953-962. PubMed ID: 29059162
[TBL] [Abstract][Full Text] [Related]
14. MGMT inhibition suppresses survivin expression in pancreatic cancer.
Bobustuc GC; Patel A; Thompson M; Srivenugopal KS; Frick J; Weese J; Konduri SD
Pancreas; 2015 May; 44(4):626-35. PubMed ID: 25875800
[TBL] [Abstract][Full Text] [Related]
15. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
16. miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer.
Wei F; Liu Y; Guo Y; Xiang A; Wang G; Xue X; Lu Z
Mol Cancer; 2013 Jul; 12():81. PubMed ID: 23886294
[TBL] [Abstract][Full Text] [Related]
17. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
18. Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice.
Colon J; Basha MR; Madero-Visbal R; Konduri S; Baker CH; Herrera LJ; Safe S; Sheikh-Hamad D; Abudayyeh A; Alvarado B; Abdelrahim M
Invest New Drugs; 2011 Feb; 29(1):41-51. PubMed ID: 19851711
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor.
Rödel C; Haas J; Groth A; Grabenbauer GG; Sauer R; Rödel F
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1341-7. PubMed ID: 12654446
[TBL] [Abstract][Full Text] [Related]
20. The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression.
Liu X; Abdelrahim M; Abudayyeh A; Lei P; Safe S
Mol Cancer Ther; 2009 May; 8(5):1207-17. PubMed ID: 19435870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
